The Future of Spinal Cord Injury Treatment: From Organoids to Regeneration
For the half a million people worldwide living with the debilitating effects of spinal cord injuries, hope is on the horizon. Despite being a leading cause of permanent disability, effective therapies have remained elusive – until now. Scientists are pioneering new approaches, leveraging the power of human spinal cord organoids to accelerate the development of regenerative treatments.
Miniature Spinal Cords: A Breakthrough in Research
Researchers at Northwestern University have successfully grown three-dimensional organoids that mimic the structure and response to injury of the human spinal cord. These “spinal cords in a dish,” created from human induced pluripotent stem cells (iPSCs), are proving to be invaluable tools for testing potential therapies. The organoids accurately replicate key features of spinal cord injuries, including immediate neuronal death and the formation of glial scars.
Introducing a laceration using a scalpel in the spinal cord organoids resulted in cell death near the injury site (red). Live cells are stained green.
Samuel Stupp/Northwestern University
The Glial Scar: A Double-Edged Sword
Following a spinal cord injury, a glial scar forms at the site of damage. While initially protective – segregating the injury and limiting inflammation – this scar also presents a significant barrier to nerve regeneration. The scar is composed of elongated astrocytes, fibroblasts, and microglia, secreting substances that inhibit axon growth. Researchers are exploring strategies to prevent scar formation, resolve existing scars, or help nerve fibers navigate through them.
‘Dancing Molecules’ and the Promise of Regeneration
One promising avenue involves supramolecular therapeutic peptides, nicknamed “dancing molecules.” These molecules, developed by the Northwestern team, are designed to interact with receptors on nerve cells, encouraging axon regrowth. In previous studies, this therapy reversed paralysis in mice. Applying the therapy to the human spinal cord organoids resulted in a significant reduction in glial scarring and promoted axonal regeneration, mirroring the positive results seen in animal models.
Introducing a contusion injury using a blunt impactor in the spinal cord organoids led to cell death (red). Live cells are stained green.
Samuel Stupp/Northwestern University
The Role of Microglia in Injury and Recovery
Recent advancements have incorporated microglia – the immune cells of the central nervous system – into the spinal cord organoid models. This addition creates a more realistic representation of the inflammatory response following injury. The “dancing molecule” therapy demonstrated a reduction in pro-inflammatory factors when applied to organoids containing microglia, suggesting a potential to modulate the immune response and promote healing.
Future Trends and Potential Therapies
The development of these human spinal cord organoid models is expected to accelerate the discovery of new therapies. Researchers are exploring several promising strategies, including:
- Cell Transplantation: Introducing healthy cells into the injured area to replace damaged neurons.
- Cell Reprogramming: Converting existing cells into neurons to promote regeneration.
- Targeting the Glial Scar: Developing therapies to modify the composition of the scar, making it more permissive to axon growth.
- Immunomodulation: Controlling the inflammatory response to minimize damage and promote healing.
Spinal cord organoids treated with the bioactive scaffold showed increased neurite growth (left) compared to organoids treated with a control solution (right).
Samuel Stupp/Northwestern University
FAQ
What are spinal cord organoids?
Spinal cord organoids are three-dimensional, miniature versions of the spinal cord grown in a lab from human cells. They mimic the structure and function of the real spinal cord.
What is the glial scar?
The glial scar is a barrier that forms after spinal cord injury. While it protects the injury site, it also prevents nerve regeneration.
How do ‘dancing molecules’ operate?
These molecules interact with receptors on nerve cells, encouraging axon regrowth and promoting healing.
The development of human spinal cord organoids represents a significant leap forward in spinal cord injury research. As these models grow more sophisticated, they will undoubtedly unlock new insights into the complex mechanisms of injury and recovery, paving the way for effective therapies and a brighter future for those affected by these devastating injuries.
Learn more about the latest advancements in neurological research. Explore our other articles or subscribe to our newsletter for regular updates.
